
Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations or Future HIV Remission Options
Author(s) -
K. Dubé,
D. M. Campbell,
K. E. Perry,
J. T. Kanazawa,
P. Saberi,
J. A. Sauceda,
T. Poteat,
D. Evans
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/xjd3-8075
Subject(s) - antiretroviral therapy , human immunodeficiency virus (hiv) , medicine , antiretroviral treatment , psychology , family medicine , viral load